Invention to Venture Workshop Supports Entrepreneurs, Investors

“What is the best way to take our inventions forward?” asked Monica Jablonski, professor of ophthalmology at The University of Tennessee Health Science Center. “I need to reeducate myself on decisions of how to go forward.” Jablonski, an inventor of a novel macular degeneration treatment, was one of more than 70 participants at the Invention… Read More

Group A Streptococcus Vaccine on Path for Commercialization with Clinical Testing Agreement

An international collaboration between Vaxent, a Memphis-based early stage vaccine development company in the Memphis Bioworks Foundation Incubator, and The Pan-Provincial Vaccine Enterprise Inc. (PREVENT), a Centre of Excellence for Commercialization and Research (CECR) in Saskatchewan, has put a vaccine for group A streptococcus (Strep-A) back on the path for potential commercialization. Under the terms… Read More